Urine-based nematode chemotaxis assay (N-NOSE) as a predictor of recurrence after curative surgery for resectable pancreatic cancer: preliminary data and single center experience.

BMC Surg · 2025 · PMC12752154 · PMID 41462185

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

showed a trendp = 0.056so close (0.05 < p ≤ 0.1)

Kaplan–Meier analysis showed a trend toward shorter recurrence-free survival in patients positive for N-NOSE before treatment compared with those negative (log-rank p = 0.056) (Supplementary Figure S1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.